SCHEMBL6480501

SCHEMBL6480501

CCOC(=O)c1c(-c2cc[nH]n2)[nH]c2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.53
ALDH1A1 P00352 7/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPT P10636 3/20 0.53
LMNA P02545 3/20 0.53
HPGD P15428 3/20 0.53
MAPK10 P53779 2/20 0.53
HSD17B10 Q99714 2/20 0.53
GAA P10253 1/20 0.53
ALOX5 P09917 1/20 0.50
ADORA3 P0DMS8 1/20 0.49
AURKA O14965 1/20 0.49
RIPK1 Q13546 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HCRTR1 O43613 1/20 0.49
RAB9A P51151 1/20 0.49
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
NPC1 O15118 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30482846 0.81 ALDH1A1 (0.76) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5244534 0.79 KDM4E (0.55) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL2885446 0.78 NR4A2 (0.71) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL3276393 0.76 TUBB4A (0.67) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL14710592 0.76 MAPT (0.62) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL22443316 0.75 MEN1 (0.54) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5240966 0.75 ALOX5 (0.56) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL7215720 0.75 ALOX5 (0.56) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL30337732 0.74 TUBB4A (0.57) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL14398894 0.74 KDM4E (0.61) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 KDM4E 765/4885ALDH1A1 2469/4885MEN1 2784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.